HAP/VAP Diagnosis in Critically Ill Septic Patients Using a Multiplex PCR Array
Key facts
- Who runs it
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Where
- Italy4 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 126 people, planned
- Started
- 3 Apr 2024
- Expected to end
- 1 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Lower tract respiratory samples
- Multiplex PCR assay (Film-array Pneumonia Panel Plus)
- Lower respiratory tract standard culture
- Blood sample standard culture
- Record updated
- 13 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Suspicion of HAP/VAP (clinical/radiological/laboratory criteria)
- Availability to perform tracheal aspirates or broncoalveolar lavage within 1 hour from clinical suspicion
- Life expectancy ≥ 48 hours
- Signed written informed consent
Who cannot take part
- Concomitant participating in other interventional trial
- Pregnancy,
- Refusal to sign informed consent
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Multicenter, randomized, controlled, open-label trial to assess if semiquantitative multiplex PCR assay, as compared to conventional microbiology, can reduce the percentage of patients without microbiological diagnosis in the first 24 hours from HAP/VAP suspicion, thus allowing early de-escalation.
The 2 groups in the trial
- Film-array Pneumonia Panel Plus groupTreatment being tested
Patients with suspected HAP or VAP in which lower tract respiratory samples are analyzed with new multiplex PCR assay (Film-array Pneumonia Panel Plus)
Treatment: Lower tract respiratory samples, Multiplex PCR assay (Film-array Pneumonia Panel Plus), Lower respiratory tract standard culture, and Blood sample standard culture
- Standard culture group (control group)Existing treatment, for comparison
Patients with suspected HAP or VAP in which lower tract respiratory samples are analyzed with standard culture
Treatment: Lower tract respiratory samples, Lower respiratory tract standard culture, and Blood sample standard culture
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- HAP/VAP Diagnosis in Critically Ill Septic Patients Using a Multiplex PCR Assay: A Multicenter Randomized Open-Label Trial. THE LIGHTNING STUDY
- Record updated
- 13 October 2026